TY - JOUR T1 - Surveillance patterns of cervical cancer patients treated with conization alone JF - International Journal of Gynecologic Cancer JO - Int J Gynecol Cancer SP - 1129 LP - 1135 DO - 10.1136/ijgc-2020-001338 VL - 30 IS - 8 AU - Silvana Pedra Nobre AU - Varvara Mazina AU - Alexia Iasonos AU - Qin C Zhou AU - Yukio Sonoda AU - Ginger Gardner AU - Kara Long-Roche AU - Mario M Leitao AU - Nadeem R Abu-Rustum AU - Jennifer J Mueller Y1 - 2020/08/01 UR - http://ijgc.bmj.com/content/30/8/1129.abstract N2 - Objectives To determine surveillance patterns of stage I cervical cancer after cervical conization.Methods A 25-question electronic survey was sent to members of the Society of Gynecologic Oncology. Provider demographics, surveillance during year 1, years 1–3, and >3 years after cervical conization, use of pelvic examination, cytology, Human papillomavirus testing, colposcopy, and endocervical curettage were queried. Data were analyzed.Results 239/1175 (20.1%) responses were collected over a 5-week study period. All providers identified as gynecologic oncologists. During year 1, 66.7% of providers perform pelvic examination and 37.1% perform cytology every 3 months. During years 1–3, 61.6% perform pelvic examination and 46% perform cytology every 6 months. At >3 years, 54.4% perform pelvic examination every 6 months and 43% perform annual pelvic examination. 66.7% of respondents perform cytology annually, and 51.9% perform annual Human papilloma virus testing. 85% of providers do not offer routine colposcopy and 60% do not offer endocervical curettage at any point during 5-year follow-up. 76.3% of respondents screen patients for Human papilloma virus vaccination.Conclusions To date, there are no specific surveillance guidelines for patients with stage I cervical cancer treated with cervical conization. The most common surveillance practice reported is pelvic examination with or without cytology every 3 months in year 1 and every 6 months thereafter. However, wide variation exists in visit frequency, cytology, and Human papillomavirus testing, and there is a clear trend away from using colposcopy and endocervical curettage. These disparate surveillance practices indicate a need for well-defined, uniform surveillance guidelines. ER -